- Home
- DKI vs XXII Comparison
DKI vs XXII Comparison
Compare DKI & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DKI | XXII |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 6.1M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | DKI | XXII |
|---|---|---|
| Price | $0.39 | $0.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 129.1K | ★ 167.9K |
| Earning Date | 02-11-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 26.19 | N/A |
| Revenue | $10,204,329.00 | ★ $20,346,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $79.56 |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | ★ 100.46 | 16.98 |
| 52 Week Low | $0.30 | $0.75 |
| 52 Week High | $15.00 | $287.27 |
Technical Indicators
Market Signals| Indicator | DKI | XXII |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 45.85 |
| Support Level | N/A | $0.75 |
| Resistance Level | N/A | $0.88 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 48.35 |
Price Performance
Historical ComparisonAbout DKI DarkIris Inc. Class A Ordinary Shares
Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.